The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomics Personalized Health-Global Market Insights and Sales Trends 2024
Synopsis
The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.
The global Genomics Personalized Health market size is expected to reach US$ 16780 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Genomics Personalized Health in various end use industries. The expanding demands from the Academics & Research Institutes and Diagnostic Centers, are propelling Genomics Personalized Health market. NGS Platforms, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RT-PCR segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomics Personalized Health market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomics Personalized Health market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomics Personalized Health, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomics Personalized Health market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomics Personalized Health market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomics Personalized Health sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomics Personalized Health covered in this report include QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc.
The global Genomics Personalized Health market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
QIAGEN
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Lonza
INVITAE
Genetic Technologies
Interleukin Genetics
Eastern Biotech
DNA Genotek
UBiome
XCode Life
Global Genomics Personalized Health market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomics Personalized Health market, Segment by Type:
NGS Platforms
RT-PCR
Microarray
Genetic Analyzers
Global Genomics Personalized Health market, by Application
Academics & Research Institutes
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomics Personalized Health companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.
The global Genomics Personalized Health market size is expected to reach US$ 16780 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Genomics Personalized Health in various end use industries. The expanding demands from the Academics & Research Institutes and Diagnostic Centers, are propelling Genomics Personalized Health market. NGS Platforms, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RT-PCR segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomics Personalized Health market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomics Personalized Health market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomics Personalized Health, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomics Personalized Health market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomics Personalized Health market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomics Personalized Health sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomics Personalized Health covered in this report include QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc.
The global Genomics Personalized Health market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
QIAGEN
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Lonza
INVITAE
Genetic Technologies
Interleukin Genetics
Eastern Biotech
DNA Genotek
UBiome
XCode Life
Global Genomics Personalized Health market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomics Personalized Health market, Segment by Type:
NGS Platforms
RT-PCR
Microarray
Genetic Analyzers
Global Genomics Personalized Health market, by Application
Academics & Research Institutes
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomics Personalized Health companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomics Personalized Health
1.1 Genomics Personalized Health Market Overview
1.1.1 Genomics Personalized Health Product Scope
1.1.2 Genomics Personalized Health Market Status and Outlook
1.2 Global Genomics Personalized Health Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomics Personalized Health Market Size by Region (2018-2029)
1.4 Global Genomics Personalized Health Historic Market Size by Region (2018-2023)
1.5 Global Genomics Personalized Health Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomics Personalized Health Market Size (2018-2029)
1.6.1 North America Genomics Personalized Health Market Size (2018-2029)
1.6.2 Europe Genomics Personalized Health Market Size (2018-2029)
1.6.3 Asia-Pacific Genomics Personalized Health Market Size (2018-2029)
1.6.4 Latin America Genomics Personalized Health Market Size (2018-2029)
1.6.5 Middle East & Africa Genomics Personalized Health Market Size (2018-2029)
2 Genomics Personalized Health Market by Type
2.1 Introduction
2.1.1 NGS Platforms
2.1.2 RT-PCR
2.1.3 Microarray
2.1.4 Genetic Analyzers
2.2 Global Genomics Personalized Health Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomics Personalized Health Historic Market Size by Type (2018-2023)
2.2.2 Global Genomics Personalized Health Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomics Personalized Health Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomics Personalized Health Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomics Personalized Health Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomics Personalized Health Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomics Personalized Health Revenue Breakdown by Type (2018-2029)
3 Genomics Personalized Health Market Overview by Application
3.1 Introduction
3.1.1 Academics & Research Institutes
3.1.2 Diagnostic Centers
3.2 Global Genomics Personalized Health Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomics Personalized Health Historic Market Size by Application (2018-2023)
3.2.2 Global Genomics Personalized Health Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomics Personalized Health Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomics Personalized Health Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomics Personalized Health Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomics Personalized Health Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomics Personalized Health Revenue Breakdown by Application (2018-2029)
4 Genomics Personalized Health Competition Analysis by Players
4.1 Global Genomics Personalized Health Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomics Personalized Health as of 2022)
4.3 Date of Key Players Enter into Genomics Personalized Health Market
4.4 Global Top Players Genomics Personalized Health Headquarters and Area Served
4.5 Key Players Genomics Personalized Health Product Solution and Service
4.6 Competitive Status
4.6.1 Genomics Personalized Health Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 QIAGEN
5.1.1 QIAGEN Profile
5.1.2 QIAGEN Main Business
5.1.3 QIAGEN Genomics Personalized Health Products, Services and Solutions
5.1.4 QIAGEN Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.1.5 QIAGEN Recent Developments
5.2 Illumina
5.2.1 Illumina Profile
5.2.2 Illumina Main Business
5.2.3 Illumina Genomics Personalized Health Products, Services and Solutions
5.2.4 Illumina Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.2.5 Illumina Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Genomics Personalized Health Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Recent Developments
5.4 Bio-Rad
5.4.1 Bio-Rad Profile
5.4.2 Bio-Rad Main Business
5.4.3 Bio-Rad Genomics Personalized Health Products, Services and Solutions
5.4.4 Bio-Rad Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Genomics Personalized Health Products, Services and Solutions
5.5.4 Roche Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Lonza
5.6.1 Lonza Profile
5.6.2 Lonza Main Business
5.6.3 Lonza Genomics Personalized Health Products, Services and Solutions
5.6.4 Lonza Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.6.5 Lonza Recent Developments
5.7 INVITAE
5.7.1 INVITAE Profile
5.7.2 INVITAE Main Business
5.7.3 INVITAE Genomics Personalized Health Products, Services and Solutions
5.7.4 INVITAE Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.7.5 INVITAE Recent Developments
5.8 Genetic Technologies
5.8.1 Genetic Technologies Profile
5.8.2 Genetic Technologies Main Business
5.8.3 Genetic Technologies Genomics Personalized Health Products, Services and Solutions
5.8.4 Genetic Technologies Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.8.5 Genetic Technologies Recent Developments
5.9 Interleukin Genetics
5.9.1 Interleukin Genetics Profile
5.9.2 Interleukin Genetics Main Business
5.9.3 Interleukin Genetics Genomics Personalized Health Products, Services and Solutions
5.9.4 Interleukin Genetics Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.9.5 Interleukin Genetics Recent Developments
5.10 Eastern Biotech
5.10.1 Eastern Biotech Profile
5.10.2 Eastern Biotech Main Business
5.10.3 Eastern Biotech Genomics Personalized Health Products, Services and Solutions
5.10.4 Eastern Biotech Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.10.5 Eastern Biotech Recent Developments
5.11 DNA Genotek
5.11.1 DNA Genotek Profile
5.11.2 DNA Genotek Main Business
5.11.3 DNA Genotek Genomics Personalized Health Products, Services and Solutions
5.11.4 DNA Genotek Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.11.5 DNA Genotek Recent Developments
5.12 UBiome
5.12.1 UBiome Profile
5.12.2 UBiome Main Business
5.12.3 UBiome Genomics Personalized Health Products, Services and Solutions
5.12.4 UBiome Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.12.5 UBiome Recent Developments
5.13 XCode Life
5.13.1 XCode Life Profile
5.13.2 XCode Life Main Business
5.13.3 XCode Life Genomics Personalized Health Products, Services and Solutions
5.13.4 XCode Life Genomics Personalized Health Revenue (US$ Million) & (2018-2023)
5.13.5 XCode Life Recent Developments
6 North America
6.1 North America Genomics Personalized Health Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genomics Personalized Health Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomics Personalized Health Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomics Personalized Health Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomics Personalized Health Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomics Personalized Health Market Dynamics
11.1 Genomics Personalized Health Industry Trends
11.2 Genomics Personalized Health Market Drivers
11.3 Genomics Personalized Health Market Challenges
11.4 Genomics Personalized Health Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
